Skip to main content
. 2014 Dec;7(9):487–488.

Table 4.

Projected Cholesterol-Lowering Medications Utilization

Patients receiving cholesterol-lowering medications Patients in a commercial plan, N (%) (N = 4,402,866) Patients in a Medicaid plan, N (%) (N = 2,173,914) Patients in a Medicare plan, N (%) (N = 7,537,720) Total population, N (%) (N = 14,114,500)
Statin users, by dosing intensitya Low-intensity statin 27,252 (4.4) 9342 (7.3) 248,729 (6.0) 285,323 (5.8)
Moderate-intensity statin 392,928 (64.2) 90,642 (70.8) 2,566,826 (61.8) 3,050,396 (62.3)
High-intensity statin 192,302 (31.4) 28,021 (21.9) 1,336,627 (32.2) 1,556,950 (31.8)
Total 612,482 (13.91) 128,005 (5.89) 4,152,182 (55.09) 4,892,668 (34.66)
Statin and nonstatin cholesterol-lowering medication usersb Total 0 (0) 0 (0) 0 (0) 0 (0)
Nonstatin cholesterol-lowering medication users Bile acid–binding resins 5667 (22.4) 1000 (19.1) 48,163 (33.4) 54,831 (31.4)
Cholesterol absorption inhibitors 4801 (19.0) 378 (7.2) 41,549 (28.8) 46,728 (26.8)
Fibrates 13,270 (52.5) 4204 (80.1) 77,550 (53.8) 95,024 (54.4)
Niacin 3901 (15.4) 790 (15.1) 21,231 (14.7) 25,922 (14.8)
Omega-3 fatty acids 7018 (27.8) 535 (10.2) 16,180 (11.2) 23,733 (13.6)
Total 25,257 (0.57) 5247 (0.24) 144,137 (1.91) 174,641 (1.24)
All cholesterol-lowering medication usersc Total 637,739 (14.48) 133,252 (6.13) 4,296,319 (57.00) 5,067,309 (35.90)
Patients aged 40–75 years not receiving cholesterol-lowering medications
With diabetes claims 0 (0) 0 (0) 0 (0) 0 (0)
With hypertension claims, but no diabetes medication claim 92,297 (6.51) 16,516 (6.42) 304,613 (17.18) 413,426 (11.99)
Overall total 1,418,731 (32.22) 257,067 (11.83) 1,772,803 (23.52) 3,448,601 (24.43)
a

See Table 1 for statin dosing intensity definitions.

b

These patients are receiving a statin and a nonstatin cholesterol-lowering medication, and these counts are not mutually exclusive of the patients counted under the statin and the nonstatin cholesterol-lowering medication user groups.

c

Unique members who are receiving any cholesterol-lowering medications.